Join us in-person for this CME symposium held during CHEST 2026
Navigating the Evolving Treatment Landscape in Fibrosing ILD:
A Multidisciplinary Case-Based Approach
Breakfast will be served for attendees.
Tuesday, October 20, 2026
6-6:30 a.m. (MST): Check in and Breakfast
6:30-7:30 a.m. (MST): Educational Program
Sheraton Phoenix Downtown
Phoenix Ballroom D&E
340 N 3rd St, Phoenix, AZ 85004
Add to Calendar
Fibrosing interstitial lung disease (ILD) presents complex challenges in recognizing progression, selecting appropriate treatment, and coordinating multidisciplinary care. In this interactive CME breakfast symposium, experts in pulmonology, rheumatology, and radiology will use practical, case-based discussion to examine evolving approaches to the assessment and management of fibrosing ILD.
Using HRCT findings and multidisciplinary perspectives, faculty will explore how to recognize progressive pulmonary fibrosis, identify clinical factors that may warrant treatment initiation or reassessment, integrate immunomodulatory and antifibrotic approaches when appropriate, and evaluate new and emerging evidence in the context of individualized patient care. Attendees will gain practical strategies for navigating complex treatment decisions and improving longitudinal management of patients with fibrosing ILD.
Program Faculty:
Melissa Griffith, MD, RhMSUS
Associate Professor of Medicine
Division of Rheumatology
University of Colorado School of Medicine
Aurora, CO
David A. Lynch, MB BCh
Professor of Radiology
Department of Radiology
National Jewish Health
Denver, CO
Joshua J. Solomon, MD
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Section of Critical Care Medicine
Director, Center for Interstitial Lung Disease
National Jewish Health
Denver, CO
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@NJHealth.org.
Support:
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Registration Information:
If interested in attending, please register below. This CME symposium is complimentary for attendees.
Attendees:
- Must be registered as part of the CHEST 2026 Conference to attend this event.
- May begin arriving at 6 a.m. for check-in and breakfast.
- Please arrive early, as seating and food may be limited.
Add to Calendar